 |
Oxford Vacmedix
Last updated: April 17, 2024
Shisong Jiang, Founder and Chief Scientific Officer
Country: UK | Funding: $12.5M (+)
Website: http://www.oxfordvacmedix.com/
Oxford Vacmedix develops therapeutic agents for the treatment of cancer based on the Recombinant Overlapping Peptides (ROP).
Website: http://www.oxfordvacmedix.com/
Oxford Vacmedix develops therapeutic agents for the treatment of cancer based on the Recombinant Overlapping Peptides (ROP).
